Bob Marshall
RWLK 11.08.2024
About Gravity Analytica
Recent News
- 01.13.2025 - Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities
- 01.13.2025 - Lifeward Cancels Its Extraordinary General Meeting of Shareholders
- 01.08.2025 - Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Recent Filings
BobMarshall
Bob Marshall has served on our board since November 2024. Mr. Marshall serves as the Chief Financial Officer and Treasurer of Lantheus Holdings, Inc., a publicly traded radiopharmaceutical company, where he has worked since September 2018. Prior to joining Lantheus, Mr. Marshall spent 16 years with Zimmer Biomet Holdings, Inc., a publicly traded global medical device company with a leading position in musculoskeletal health, in which he held various senior leadership roles, including Vice President, Investor Relations and Corporate Treasurer, and most recently Vice President, Americas Finance, for the U.S., Canadian and Latin American commercial markets. Before Zimmer Biomet, Mr. Marshall was employed with Brown & Williamson Tobacco, a subsidiary of British American Tobacco, p.l.c., in Louisville, Kentucky, where he held several positions of increasing responsibility. Mr. Marshall holds a B.S. degree in Business Administration from the University of Notre Dame and an M.B.A. degree from Indiana University.